Routes of
administration Oral CAS Number 839713-36-9 ChemSpider 9858284 Molar mass 437.238 g/mol | ATC code none PubChem CID 11683556 UNII 4ZA73QEW2P | |
 | ||
Axovant nelotanserin for lewy body dementia
Nelotanserin (APD-125) is a drug developed by Arena Pharmaceuticals which acts as an inverse agonist on the serotonin receptor subtype 5-HT2A. It was shown to be effective and well tolerated in clinical trials, but development was halted in December 2008 because the substance did not meet the trial's endpoints. Research continues on newer analogues which may potentially be more successful.
References
Nelotanserin Wikipedia(Text) CC BY-SA